Cancer/Tumor Profiling Market Size, Share, Growth Report 2032

Creator: Zion Market Research
License: https://www.zionmarketresearch.com/privacy-policy

Global Cancer/Tumor Profiling Market By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), By Biomarker Type (Genomic Biomarker, Protein Biomarker, and Others), By Application (Research and Clinical) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2030-

Category: Pharmaceutical Report Format : PDF Pages: 245 Report Code: ZMR-1160 Published Date: Dec-2022 Status : Published

The global Cancer/Tumor Profiling market size was valued USD 9.5 billion in 2021 and is expected to rise to USD 25.3 billion by 2030 at a CAGR of 11.5%.

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Cancer/Tumor Profiling Market, (2022 - 2030) (USD Billion)
- 2.2 Global Cancer/Tumor Profiling Market : snapshot
Chapter 3. Global Cancer/Tumor Profiling Market - Industry Analysis
- 3.1 Cancer/Tumor Profiling Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increased cancer incidence and improvements in tumor profiling technology to drive the market growth
- 3.3 Market Restraints
  - 3.3.1. Collection and storage issues
- 3.4 Market Opportunities
  - 3.4.1. Increasing preference for personalized medicine
- 3.5 Market Challenges
  - 3.5.1. Low biomarker discovery-to-approval ratio
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Technology
  - 3.7.2 Market attractiveness analysis By Cancer Type
  - 3.7.3 Market attractiveness analysis By Biomarker Type
  - 3.7.4 Market attractiveness analysis By Application
Chapter 4. Global Cancer/Tumor Profiling Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Cancer/Tumor Profiling Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Cancer/Tumor Profiling Market - Technology Analysis
- 5.1 Global Cancer/Tumor Profiling Market overview: By Technology
  - 5.1.1 Global Cancer/Tumor Profiling Market share, By Technology, 2021 and 2030
- 5.2 Immunoassays
  - 5.2.1 Global Cancer/Tumor Profiling Market by Immunoassays, 2022 - 2030 (USD Billion)
- 5.3 Next-Generation Sequencing
  - 5.3.1 Global Cancer/Tumor Profiling Market by Next-Generation Sequencing, 2022 - 2030 (USD Billion)
- 5.4 Polymerase Chain Reaction
  - 5.4.1 Global Cancer/Tumor Profiling Market by Polymerase Chain Reaction, 2022 - 2030 (USD Billion)
- 5.5 Mass Spectrometry
  - 5.5.1 Global Cancer/Tumor Profiling Market by Mass Spectrometry, 2022 - 2030 (USD Billion)
- 5.6 In-Situ Hybridization
  - 5.6.1 Global Cancer/Tumor Profiling Market by In-Situ Hybridization, 2022 - 2030 (USD Billion)
- 5.7 Microarrays
  - 5.7.1 Global Cancer/Tumor Profiling Market by Microarrays, 2022 - 2030 (USD Billion)
- 5.8 Others
  - 5.8.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
Chapter 6. Global Cancer/Tumor Profiling Market - Cancer Type Analysis
- 6.1 Global Cancer/Tumor Profiling Market overview: By Cancer Type
  - 6.1.1 Global Cancer/Tumor Profiling Market share, By Cancer Type, 2021 and 2030
- 6.2 Breast Cancer
  - 6.2.1 Global Cancer/Tumor Profiling Market by Breast Cancer, 2022 - 2030 (USD Billion)
- 6.3 Lung Cancer
  - 6.3.1 Global Cancer/Tumor Profiling Market by Lung Cancer, 2022 - 2030 (USD Billion)
- 6.4 Colorectal Cancer
  - 6.4.1 Global Cancer/Tumor Profiling Market by Colorectal Cancer, 2022 - 2030 (USD Billion)
- 6.5 Prostate Cancer
  - 6.5.1 Global Cancer/Tumor Profiling Market by Prostate Cancer, 2022 - 2030 (USD Billion)
- 6.6 Melanoma Cancer
  - 6.6.1 Global Cancer/Tumor Profiling Market by Melanoma Cancer, 2022 - 2030 (USD Billion)
- 6.7 Others
  - 6.7.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
Chapter 7. Global Cancer/Tumor Profiling Market - Biomarker Type Analysis
- 7.1 Global Cancer/Tumor Profiling Market overview: By Biomarker Type
  - 7.1.1 Global Cancer/Tumor Profiling Market share, By Biomarker Type, 2021 and 2030
- 7.2 Genomic Biomarker
  - 7.2.1 Global Cancer/Tumor Profiling Market by Genomic Biomarker, 2022 - 2030 (USD Billion)
- 7.3 Protein Biomarker
  - 7.3.1 Global Cancer/Tumor Profiling Market by Protein Biomarker, 2022 - 2030 (USD Billion)
- 7.4 Others
  - 7.4.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
Chapter 8. Global Cancer/Tumor Profiling Market - Application Analysis
- 8.1 Global Cancer/Tumor Profiling Market overview: By Application
  - 8.1.1 Global Cancer/Tumor Profiling Market share, By Application, 2021 and 2030
- 8.2 Research
  - 8.2.1 Global Cancer/Tumor Profiling Market by Research, 2022 - 2030 (USD Billion)
- 8.3 Clinical
  - 8.3.1 Global Cancer/Tumor Profiling Market by Clinical, 2022 - 2030 (USD Billion)
Chapter 9. Cancer/Tumor Profiling Market - Regional Analysis
- 9.1 Global Cancer/Tumor Profiling Market Regional Overview
- 9.2 Global Cancer/Tumor Profiling Market Share, by Region, 2021 & 2030 (USD Billion)
- 9.3. North America
  - 9.3.1 North America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
    - 9.3.1.1 North America Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4 North America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
  - 9.4.1 North America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 North America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
  - 9.5.1 North America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 North America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
  - 9.6.1 North America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 North America Cancer/Tumor Profiling Market, by Application, 2022 - 2030
  - 9.7.1 North America Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.4. Europe
  - 9.4.2 Europe Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
    - 9.4.2.1 Europe Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4 Europe Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
  - 9.4.1 Europe Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Europe Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
  - 9.5.1 Europe Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Europe Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
  - 9.6.1 Europe Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Europe Cancer/Tumor Profiling Market, by Application, 2022 - 2030
  - 9.7.1 Europe Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.5. Asia Pacific
  - 9.5.3 Asia Pacific Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
    - 9.5.3.1 Asia Pacific Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4 Asia Pacific Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
  - 9.4.1 Asia Pacific Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Asia Pacific Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
  - 9.5.1 Asia Pacific Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Asia Pacific Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
  - 9.6.1 Asia Pacific Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Asia Pacific Cancer/Tumor Profiling Market, by Application, 2022 - 2030
  - 9.7.1 Asia Pacific Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.6. Latin America
  - 9.6.4 Latin America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
    - 9.6.4.1 Latin America Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4 Latin America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
  - 9.4.1 Latin America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Latin America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
  - 9.5.1 Latin America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Latin America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
  - 9.6.1 Latin America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Latin America Cancer/Tumor Profiling Market, by Application, 2022 - 2030
  - 9.7.1 Latin America Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.7. The Middle-East and Africa
  - 9.7.5 The Middle-East and Africa Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
    - 9.7.5.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4 The Middle-East and Africa Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
  - 9.4.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 The Middle-East and Africa Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
  - 9.5.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 The Middle-East and Africa Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
  - 9.6.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 The Middle-East and Africa Cancer/Tumor Profiling Market, by Application, 2022 - 2030
  - 9.7.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
Chapter 10. Company Profiles
- 10.1 QIAGEN
  - 10.1.1 Overview
  - 10.1.2 Financials
  - 10.1.3 Product Portfolio
  - 10.1.4 Business Strategy
  - 10.1.5 Recent Developments
- 10.2 Illumina Inc.
  - 10.2.1 Overview
  - 10.2.2 Financials
  - 10.2.3 Product Portfolio
  - 10.2.4 Business Strategy
  - 10.2.5 Recent Developments
- 10.3 NeoGenomics Laboratories Inc.
  - 10.3.1 Overview
  - 10.3.2 Financials
  - 10.3.3 Product Portfolio
  - 10.3.4 Business Strategy
  - 10.3.5 Recent Developments
- 10.4 Genomic Health Inc.
  - 10.4.1 Overview
  - 10.4.2 Financials
  - 10.4.3 Product Portfolio
  - 10.4.4 Business Strategy
  - 10.4.5 Recent Developments
- 10.5 HTG Molecular Diagnostics Inc.
  - 10.5.1 Overview
  - 10.5.2 Financials
  - 10.5.3 Product Portfolio
  - 10.5.4 Business Strategy
  - 10.5.5 Recent Developments
- 10.6 Caris Life Sciences
  - 10.6.1 Overview
  - 10.6.2 Financials
  - 10.6.3 Product Portfolio
  - 10.6.4 Business Strategy
  - 10.6.5 Recent Developments
- 10.7 Helomics Corporation
  - 10.7.1 Overview
  - 10.7.2 Financials
  - 10.7.3 Product Portfolio
  - 10.7.4 Business Strategy
  - 10.7.5 Recent Developments
- 10.8 NanoString Technologies Inc.
  - 10.8.1 Overview
  - 10.8.2 Financials
  - 10.8.3 Product Portfolio
  - 10.8.4 Business Strategy
  - 10.8.5 Recent Developments
- 10.9 Sysmex Corporation
  - 10.9.1 Overview
  - 10.9.2 Financials
  - 10.9.3 Product Portfolio
  - 10.9.4 Business Strategy
  - 10.9.5 Recent Developments
- 10.10 Ribomed Biotechnologies Inc.
  - 10.10.1 Overview
  - 10.10.2 Financials
  - 10.10.3 Product Portfolio
  - 10.10.4 Business Strategy
  - 10.10.5 Recent Developments
- 10.11 Guardant Health Inc.
  - 10.11.1 Overview
  - 10.11.2 Financials
  - 10.11.3 Product Portfolio
  - 10.11.4 Business Strategy
  - 10.11.5 Recent Developments
- 10.12 Foundation Medicine
  - 10.12.1 Overview
  - 10.12.2 Financials
  - 10.12.3 Product Portfolio
  - 10.12.4 Business Strategy
  - 10.12.5 Recent Developments
- 10.13 Roche Diagnostics
  - 10.13.1 Overview
  - 10.13.2 Financials
  - 10.13.3 Product Portfolio
  - 10.13.4 Business Strategy
  - 10.13.5 Recent Developments
- 10.14 GenScript Biotech Corporation
  - 10.14.1 Overview
  - 10.14.2 Financials
  - 10.14.3 Product Portfolio
  - 10.14.4 Business Strategy
  - 10.14.5 Recent Developments
- 10.15 Tempus Labs
  - 10.15.1 Overview
  - 10.15.2 Financials
  - 10.15.3 Product Portfolio
  - 10.15.4 Business Strategy
  - 10.15.5 Recent Developments
- 10.16 Boreal Genomics Inc
  - 10.16.1 Overview
  - 10.16.2 Financials
  - 10.16.3 Product Portfolio
  - 10.16.4 Business Strategy
  - 10.16.5 Recent Developments
- 10.17 Perthera
  - 10.17.1 Overview
  - 10.17.2 Financials
  - 10.17.3 Product Portfolio
  - 10.17.4 Business Strategy
  - 10.17.5 Recent Developments
- 10.18 Agendia
  - 10.18.1 Overview
  - 10.18.2 Financials
  - 10.18.3 Product Portfolio
  - 10.18.4 Business Strategy
  - 10.18.5 Recent Developments
- 10.19 Omniseq
  - 10.19.1 Overview
  - 10.19.2 Financials
  - 10.19.3 Product Portfolio
  - 10.19.4 Business Strategy
  - 10.19.5 Recent Developments
- 10.20 Histogene X
  - 10.20.1 Overview
  - 10.20.2 Financials
  - 10.20.3 Product Portfolio
  - 10.20.4 Business Strategy
  - 10.20.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cancer/Tumor Profiling Market attractiveness, By Technology
6. Global Cancer/Tumor Profiling Market attractiveness, By Cancer Type
7. Global Cancer/Tumor Profiling Market attractiveness, By Biomarker Type
8. Global Cancer/Tumor Profiling Market attractiveness, By Application
9. Global Cancer/Tumor Profiling Market share by Technology, 2022 and 2030 (USD Billion)
10. Global Cancer/Tumor Profiling Market by Immunoassays, 2022 - 2030 (USD Billion)
11. Global Cancer/Tumor Profiling Market by Next-Generation Sequencing, 2022 - 2030 (USD Billion)
12. Global Cancer/Tumor Profiling Market by Polymerase Chain Reaction, 2022 - 2030 (USD Billion)
13. Global Cancer/Tumor Profiling Market by Mass Spectrometry, 2022 - 2030 (USD Billion)
14. Global Cancer/Tumor Profiling Market by In-Situ Hybridization, 2022 - 2030 (USD Billion)
15. Global Cancer/Tumor Profiling Market by Microarrays, 2022 - 2030 (USD Billion)
16. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
17. Global Cancer/Tumor Profiling Market share by Cancer Type, 2022 and 2030 (USD Billion)
18. Global Cancer/Tumor Profiling Market by Breast Cancer, 2022 - 2030 (USD Billion)
19. Global Cancer/Tumor Profiling Market by Lung Cancer, 2022 - 2030 (USD Billion)
20. Global Cancer/Tumor Profiling Market by Colorectal Cancer, 2022 - 2030 (USD Billion)
21. Global Cancer/Tumor Profiling Market by Prostate Cancer, 2022 - 2030 (USD Billion)
22. Global Cancer/Tumor Profiling Market by Melanoma Cancer, 2022 - 2030 (USD Billion)
23. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
24. Global Cancer/Tumor Profiling Market share by Biomarker Type, 2022 and 2030 (USD Billion)
25. Global Cancer/Tumor Profiling Market by Genomic Biomarker, 2022 - 2030 (USD Billion)
26. Global Cancer/Tumor Profiling Market by Protein Biomarker, 2022 - 2030 (USD Billion)
27. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
28. Global Cancer/Tumor Profiling Market share by Application, 2022 and 2030 (USD Billion)
29. Global Cancer/Tumor Profiling Market by Research, 2022 - 2030 (USD Billion)
30. Global Cancer/Tumor Profiling Market by Clinical, 2022 - 2030 (USD Billion)
31. Global Cancer/Tumor Profiling Market share, by Region, 2022 and 2030
32. North America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
33. Europe Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
34. Asia Pacific Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
35. Latin America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
36. The Middle-East and Africa Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)

Table Of Tables

1. Global Cancer/Tumor Profiling Market: Snapshot
2. Drivers of the Cancer/Tumor Profiling Market: impact analysis
3. North America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
4. North America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
5. North America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
6. North America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
7. U.S. Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
8. U.S. Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
9. U.S. Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
10. U.S. Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
11. Canada Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
12. Canada Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
13. Canada Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
14. Canada Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
15. Europe Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
16. Europe Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
17. Europe Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
18. Europe Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
19. Germany Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
20. Germany Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
21. Germany Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
22. Germany Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
23. France Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
24. France Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
25. France Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
26. France Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
27. U.K. Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
28. U.K. Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
29. U.K. Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
30. U.K. Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
31. Italy Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
32. Italy Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
33. Italy Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
34. Italy Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
35. Spain Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
36. Spain Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
37. Spain Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
38. Spain Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
39. Rest of Europe Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
40. Rest of Europe Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
41. Rest of Europe Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
42. Rest of Europe Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
43. Asia Pacific Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
44. Asia Pacific Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
45. Asia Pacific Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
46. Asia Pacific Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
47. China Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
48. China Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
49. China Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
50. China Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
51. Japan Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
52. Japan Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
53. Japan Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
54. Japan Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
55. India Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
56. India Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
57. India Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
58. India Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
59. South Korea Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
60. South Korea Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
61. South Korea Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
62. South Korea Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
63. South-East Asia Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
64. South-East Asia Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
65. South-East Asia Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
66. South-East Asia Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
67. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
68. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
69. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
70. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
71. Latin America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
72. Latin America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
73. Latin America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
74. Latin America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
75. Brazil Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
76. Brazil Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
77. Brazil Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
78. Brazil Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
79. Mexico Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
80. Mexico Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
81. Mexico Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
82. Mexico Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
83. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
84. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
85. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
86. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
87. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
88. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
89. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
90. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
91. GCC Countries Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
92. GCC Countries Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
93. GCC Countries Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
94. GCC Countries Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
95. South Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
96. South Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
97. South Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
98. South Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
99. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
100. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
101. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
102. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)

Methodology

FrequentlyAsked Questions

Which key factors will influence cancer/tumor profiling market growth over 2022-2030?

The increasing prevalence of cancer and rising demand for accurate diagnosis of cancer in the early stage are expected to fuel the growth of the cancer/tumor profiling market. Moreover, the growing need for point-of-care diagnostic tests and personalized medicine in cancer/tumor profiling is anticipated to drive market growth during the forecast period.

What will be the value of cancer/tumor profiling market during 2022-2030?

According to the report, global cancer/tumor profiling market size was worth around USD 9.5 billion in 2021 and is predicted to grow to around USD 25.3 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11.5% between 2022 and 2030.

Which region will contribute notably towards cancer/tumor profiling market value?

Global cancer/tumor profiling market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the growing prevalence of chronic disease in the region.

Which are the major players leveraging cancer/tumor profiling market growth?

Global cancer/tumor profiling market is dominated by players like QIAGEN, Illumina, Inc., NeoGenomics Laboratories, Inc., Genomic Health Inc., HTG Molecular Diagnostics, Inc., Caris Life Sciences, Helomics Corporation, NanoString Technologies, Inc., Sysmex Corporation, Ribomed Biotechnologies, Inc., Guardant Health, Inc., Foundation Medicine, Roche Diagnostics, GenScript Biotech Corporation, Tempus Labs, Boreal Genomics Inc, Perthera, Agendia, Omniseq and Histogene X, among others.

Choose License Type

Single User License $4199.00 Multi User License $5199.00 Enterprise Access License $7199.00

Request Free Brochure

Ask for Customization

Free Analysis

Inquiry For Buying

RelatedNews

HappyClients

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We have secured system to process your transaction.

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed

Cancer/Tumor Profiling Market Size, Share, Growth Report 2032

Table Of Content

Table Of Figures

Table Of Tables

Methodology

Which key factors will influence cancer/tumor profiling market growth over 2022-2030?

What will be the value of cancer/tumor profiling market during 2022-2030?

Which region will contribute notably towards cancer/tumor profiling market value?

Which are the major players leveraging cancer/tumor profiling market growth?

Choose License Type

How to Order

Disclaimer

FAQs

Return Policy

Sitemap

About Us

Terms and Conditions

Contact Us

Privacy Policy

ZMR in News

Career